VRDN Market Cap & Key Metrics
Viridian Therapeutics, Inc.
$19.50
+$1.12(+6.09%)
43
Overall
60
Value
36
Tech
34
Quality
Market Cap
$2.08B
Volume
308.26K
52W Range
$13.18 - $34.29
Target Price
$36.88
VRDN market cap is $2.08B. This page lists Viridian Therapeutics, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
VRDN Key Metrics
- Market cap
- $2.08B
- EPS estimate, current year
- $-4.07
- EPS growth, 3-year
- +6.41%
- Value score
- 60
- Quality score
- 34
- Technical score
- 36
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $70.85M | $302.0K | $314.0K | $1.77M | $2.96M |
| EBITDA | -$337.19M | -$267.21M | -$235.05M | -$128.91M | -$79.29M |
| EPS | $-3.32 | $-3.07 | $-5.31 | $-4.05 | $-6.66 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VRDN | $19.50 | +6.1% | 308.26K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Viridian Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW